---
title: "Gosuncn: Currently, there is no business relationship with DeepSeek Company"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/227997222.md"
description: "Gosuncn stated on the interactive platform that the company currently has no business dealings with DeepSeek. The company has always closely monitored the innovation and application of emerging technologies and, in conjunction with its actual business needs, strives to expand the application of relevant technologies in products, research and development, and internal operational management"
datetime: "2025-02-12T07:38:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/227997222.md)
  - [en](https://longbridge.com/en/news/227997222.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/227997222.md)
generator: "portal-rs"
---

# Gosuncn: Currently, there is no business relationship with DeepSeek Company

Gosuncn stated on the interactive platform that the company currently has no business dealings with DeepSeek. The company has always closely monitored the innovation and application of emerging technologies and, in conjunction with its actual business needs, strives to expand the application of relevant technologies in products, research and development, and internal operational management

### Related Stocks

- [300098.CN](https://longbridge.com/en/quote/300098.CN.md)

## Related News & Research

- [Why the jobs report will actually be good for bonds](https://longbridge.com/en/news/298066649.md)
- [OSE Immunotherapeutics reports 24,825,111 issued shares, 29,493,665 exercisable voting rights as of Aug. 31](https://longbridge.com/en/news/298225789.md)
- [REG - Vulcan Two Group PLC - Holding(s) in Company](https://longbridge.com/en/news/298223691.md)
- [REG - Permanent TSB Group - Holding(s) in Company](https://longbridge.com/en/news/297887533.md)
- [Glycorex Transplantation signs Grupo VIDA as Brazil distributor for Glycosorb ABO](https://longbridge.com/en/news/298225826.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**